IMN || Diabetes

Younger men with goiter at higher risk for thyroid cancers

Posted on: 10/04/2014 - 16:05

PHOENIX – More than one-fourth of men under age 50 undergoing surgery for benign goiter were found to have thyroid cancers, based on

Field of Interest: Oncology

Type: News Item

Weekly exenatide shows long-term efficacy in type 2 diabetes

Posted on: 09/04/2014 - 17:30

In patents with type 2 diabetes, weekly injections with exenatide controlled hemoglobin A1c levels more effectively than did daily glargine over a 3-year period, investigators reported...

Field of Interest: Endocrinology

Type: News Item

VIDEO: PCSK9 inhibitors placed in perspective

Posted on: 07/04/2014 - 16:55

WASHINGTON – "We’re at the dawn of an era of biological therapeutics in cardiology," Dr. Peter Libby, chief of cardiovascular medicine at the Brigham and Women’s Hospital in Boston, told us...

Field of Interest: Cardiology

Type: News Item

FDA panel backs approval of inhaled insulin for type 1 and 2 diabetes

Posted on: 02/04/2014 - 17:40

HYATTSVILLE, MD. – Inhaled insulin will probably become available as a treatment option again, with a Food and Drug Administration advisory panel’s recommendation to approve an orally administered...

Field of Interest: Endocrinology

Type: News Item

Bariatric surgery’s benefit persists in type 2 diabetes

Posted on: 01/04/2014 - 14:30

WASHINGTON – Bariatric surgery combined with intensive medical therapy had a significantly greater impact on glycemic control, compared with medical therapy alone, in a <link...

Field of Interest: Endocrinology

Type: News Item

Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients

Posted on: 31/03/2014 - 20:00

WASHINGTON – Evolocumab, an investigational fully human monoclonal antibody, was associated with markedly greater LDL cholesterol reductions than ezetimibe in a phase III clinical trial of...

Field of Interest: Cardiology

Type: News Item

No improvements in left ventricular function with metformin after myocardial infarction

Posted on: 31/03/2014 - 13:00

Treatment with metformin failed to show any positive effects on left ventricular function in diabetes-free patients who presented with ST-segment elevation MI, according to the results of a...

Field of Interest: Cardiology

Type: News Item

‘Revolutionary’ LDL lowering shown in evolocumab phase III trials

Posted on: 30/03/2014 - 19:35

WASHINGTON – The novel low-density lipoprotein cholesterol–lowering agent evolocumab took day 1 of the annual meeting of the American College of Cardiology by storm on the strength of three...

Field of Interest: Cardiology

Type: News Item

Aleglitazar failed to reduce cardiovascular events in type 2 diabetes

Posted on: 30/03/2014 - 13:00

A trial of aleglitazar to improve cardiovascular outcomes in patients with type 2 diabetes who had recent-onset acute coronary syndrome has been terminated early because of a lack of efficacy and an...

Field of Interest: Cardiology

Type: News Item

Is bariatric surgery the right treatment model for obesity?

Posted on: 25/03/2014 - 21:10

WASHINGTON – Bariatric surgery has the greatest amount of data demonstrating its efficacy in reducing the comorbidities of obesity, as well as providing a long-term solution to the disease itself,...

Field of Interest: Endocrinology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters